Bioanalysis CROs in India
11 published
11 published CROs match Bioanalysis in India.
Locations in this set include India, United States, United Kingdom, China, Japan, and Netherlands.
Capabilities that show up most often in this set: Biologics (Other), Small Molecule, Biologics (Monoclonal Antibodies), Cell Therapy, and Gene Therapy.
Matching companies
ACM Global LaboratoriesGlobal clinical trial central lab and bioanalytical services provider with 40+ years of experience supporting drug development across 65+ countries.
Accutest Research LaboratoriesIndependent Indian CRO focused on BA/BE studies, Phase II–IV clinical development, and biologics bioanalysis. Operates 262 clinic beds and 21 LC-MS/MS systems across Mumbai and Vadodara.
Aragen Life SciencesGlobal CRDMO partner offering integrated discovery-to-commercialization services across small molecules and biologics, with 4000+ scientists and R&D/manufacturing campuses in Asia, North America, and Europe.
Biolivz Research Center Private LimitedTelangana-based preclinical CRO offering in vitro ADME, in vivo pharmacokinetics and toxicokinetics, preclinical bioanalysis, and in vivo pharmacology assays. Study designs are tailored to early drug development with quick turnaround.
ICBioICBio is a Bengaluru-based CRO offering bioavailability/bioequivalence studies, phase II–IV clinical trials, and LC-MS/MS bioanalysis. The excerpts cite regulatory approvals from DCGI-CDSCO, ANVISA, and EMA.
ICON plcICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.
PPDPPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific.
PerceptiveLeading clinical research organization providing preclinical to late-phase imaging, randomization and trial supply management (RTSM), and eClinical services to the global biopharmaceutical industry.
QPSQPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.
Raptim ResearchBioequivalence and bioavailability specialist with 32+ USFDA inspections cleared, running healthy-subject BA/BE and PK/PD studies, IVRT/IVPT in-vitro release and permeability testing, and Phase I to IV clinical trials.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Markdown mirror: /services/bioanalysis/india.md